Dafilon® Suture Material in Patients Undergoing Ophthalmic Surgery (OPHTHADA)

Aesculap

Status: Completed

Conditions: Eye Diseases

Treatments: Device: ophthalmic surgery

Study type: Observational

Funder types: Industry

Identifiers

NCT05968443

AAG-O-H-1913

Details and patient eligibility

About

This is an observational, retrospective postmarket clinical follow-up study and includes all patients who underwent any ophthalmic surgery using Dafilon® suture in the selected centres between 2018 and 2020, therefore no sample size can be given but the planned sample size shall be at least 200 eyes (around 100 patients depending on the number of operated eyes per patient) to conduct meaningful subgroup analysis.

Enrollment: 200 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient operated between 2018 - 2020 undergoing any ophthalmic surgery using Dafilon® suture material (Dafilon® USP (United States Pharmacopeia) sizes from 8/0 to 11/0) at the participating hospital

Exclusion criteria

• No exclusion criteria have been set